Seed Wealth Management’s Novo Nordisk NVO Stock Holding History

Seed Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$538K	Buy	14,644 +3,700	+34%	+$175K	0.37%	45
2025 Q4	$557K	Sell	10,944 -2,310	-17%	-$118K	0.38%	44
2025 Q3	$735K	Sell	13,254 -2,696	-17%	-$158K	0.51%	39
2025 Q2	$1.1M	Buy	15,950 +1,920	+14%	+$131K	0.82%	33
2025 Q1	$974K	Buy	14,030 +2,240	+19%	+$185K	0.79%	31
2024 Q4	$1.01M	Hold	11,790	–	–	0.82%	34
2024 Q3	$1.4M	Hold	11,790	–	–	1.12%	20
2024 Q2	$1.68M	Hold	11,790	–	–	1.47%	16
2024 Q1	$1.5M	Hold	11,790	–	–	1.44%	16
2023 Q4	$1.2M	Hold	11,790	–	–	1.21%	21
2023 Q3	$1.07M	Hold	11,790	–	–	1.2%	22
2023 Q2	$954K	Sell	11,790 -70	-0.6%	-$5.72K	1.01%	26
2023 Q1	$944K	Hold	11,860	–	–	1.07%	24
2022 Q4	$803K	Buy	+11,860	New	+$695K	0.92%	24

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Seed Wealth Management's NVO Position: Q1 2026 in Review

Seed Wealth Management increased its Novo Nordisk (NVO) stake by 34% in Q1 2026, buying an estimated $175K and bringing the position to 14,644 shares worth $538K. The position accounts for 0.37% of the portfolio, ranked #45.

Seed Wealth Management first reported a position in NVO in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.68M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Seed Wealth Management held 14,644 shares of Novo Nordisk worth $538K as of Q1 2026.
Seed Wealth Management bought 3,700 Novo Nordisk shares in Q1 2026, an estimated $175K.
Novo Nordisk made up 0.37% of Seed Wealth Management's portfolio in Q1 2026, its #45 holding.
Seed Wealth Management first reported a position in Novo Nordisk in Q4 2022 and has held it in 14 quarters since.
Seed Wealth Management's Novo Nordisk position peaked at $1.68M in Q2 2024.
1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Seed Wealth Management's 13F filing for Q1 2026, filed 8 Apr 2026.